• University of Southampton Featured Masters Courses
  • University of Derby Online Learning Featured Masters Courses
  • Jacobs University Bremen gGmbH Featured Masters Courses
  • University of Bristol Featured Masters Courses
  • Goldsmiths, University of London Featured Masters Courses
  • University of Edinburgh Featured Masters Courses
  • Swansea University Featured Masters Courses
  • University of Oxford Featured Masters Courses
Middlesex University Featured Masters Courses
OCAD University Featured Masters Courses
Imperial College London Featured Masters Courses
Barcelona Technology school Featured Masters Courses
Coventry University Featured Masters Courses
"cancer" AND "pharmacolog…×
0 miles

Masters Degrees (Cancer Pharmacology)

We have 54 Masters Degrees (Cancer Pharmacology)

  • "cancer" AND "pharmacology" ×
  • clear all
Showing 1 to 15 of 54
Order by 
This is an exciting time to be involved in cancer therapeutics. Based upon a greater understanding of the molecular aspects of cancer, new opportunities for therapeutic intervention have emerged that are effectively 'target orientated'. Read more
This is an exciting time to be involved in cancer therapeutics. Based upon a greater understanding of the molecular aspects of cancer, new opportunities for therapeutic intervention have emerged that are effectively 'target orientated'. These new therapeutics are quite distinct from the classical chemotherapeutic agents and they offer the prospect of truly selective cancer therapies that are tailored towards the individual patient's tumour. Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches.

The programme is designed to provide you with a 'state-of-the-art' course in modern cancer pharmacology that meets the demand of employers and provides an expert view of the available cancer medicines and the development of new cancer therapies.

It promotes advanced scholarship within specialised areas at the same time as the development of key transferable skills (in IT, communication, and time management) and research techniques. The taught component of the course provides the in depth knowledge and skills necessary to work in cancer research, and is delivered across 2 semesters through lectures, workshops, practicals and 1-to-1 tutorials with ICT staff. You will then join one of our research teams to complete the MSc research project.

Why Bradford?

-The course is hosted by the Institute of Cancer Therapeutics, which has an international reputation as a centre of excellence in Cancer Pharmacology
-It benefits from the multidisciplinary team of researchers in the field of anti-cancer drug design, synthesis, screening and pharmacology both at the University and through our extensive links with experts at other universities and industry
-You will also benefit from working in excellent research laboratories in a research-focused environment

Modules

-Molecular Basis of Cancer and Cancer Therapy
-Preclinical Models for Drug Evaluation
-Cancer Pharmacology
-Experimental Design
-Research and Analytical Methods
-Critical Appraisal of a Current Topic in Cancer Pharmacology
-Research Project (ICT)

Career support and prospects

The University is committed to helping students develop and enhance employability and this is an integral part of many programmes. Specialist support is available throughout the course from Career and Employability Services including help to find part-time work while studying, placements, vacation work and graduate vacancies. Students are encouraged to access this support at an early stage and to use the extensive resources on the Careers website.

Discussing options with specialist advisers helps to clarify plans through exploring options and refining skills of job-hunting. In most of our programmes there is direct input by Career Development Advisers into the curriculum or through specially arranged workshops.

Many students go on to study for PhDs either at Bradford or elsewhere. Recent graduates are studying at Dundee, Newcastle and Glasgow universities, and at medical schools in the UK and abroad.

Those in employment are in R&D, clinical research and teaching roles.

Read less
The use of chemotherapeutic agents to target and kill cancer cells is a central strategy in the treatment of cancers. This course describes the nature of the disease at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and on how they work. Read more
The use of chemotherapeutic agents to target and kill cancer cells is a central strategy in the treatment of cancers. This course describes the nature of the disease at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and on how they work.

More about this course

Worldwide the incidence of cancer is increasing, and is expected to reach 22 million new cases per year by 2030. In addition to treatments such as radiotherapy and surgery, chemotherapy has a vital role to play in prolonging the lives of patients.

The aims of this course are to:
-Provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving;
-Review the biology of cancer with respect to genetics, pathological considerations, and the molecular changes within cells which are associated with the progression of the disease;
-Enhance intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data;
deliver a programme of advanced study to equip you for a future career in anti-cancer drug development.

Assessment is a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.

Modular structure

The modules listed below are for the academic year 2016/17 and represent the course modules at this time. Modules and module details (including, but not limited to, location and time) are subject to change over time.

Year 1 modules include:
-Cancer Pharmacology (core, 20 credits)
-Cancer: Diagnosis and Therapy (core, 20 credits)
-Medical Genetics (core, 20 credits)
-Molecular Oncology (core, 20 credits)
-Research Project (core, 60 credits)
-Scientific Frameworks for Research (core, 20 credits)
-Advanced Drug Formulation Technologies (option, 20 credits)
-Bioinformatics and Molecular Modelling (option, 20 credits)
-Drug Discovery Technology (option, 20 credits)

After the course

This course is primarily designed for those wishing to pursue a career in anti-cancer drug development, whether in academia or within the pharmaceutical industry. The programme provides an excellent basis for further research or study.

Moving to one campus

Between 2016 and 2020 we're investing £125 million in the London Metropolitan University campus, moving all of our activity to our current Holloway campus in Islington, north London. This will mean the teaching location of some courses will change over time.

Whether you will be affected will depend on the duration of your course, when you start and your mode of study. The earliest moves affecting new students will be in September 2017. This may mean you begin your course at one location, but over the duration of the course you are relocated to one of our other campuses. Our intention is that no full-time student will change campus more than once during a course of typical duration.

All students will benefit from our move to one campus, which will allow us to develop state-of-the-art facilities, flexible teaching areas and stunning social spaces.

Read less
Clinicians, scientists and students engaged in cancer research at Newcastle share a common purpose. to improve treatment outcomes for patients with cancer. Read more
Clinicians, scientists and students engaged in cancer research at Newcastle share a common purpose: to improve treatment outcomes for patients with cancer. Work covers a broad spectrum - understanding the biological and molecular differences between normal and malignant cells and using this knowledge to develop new anti-cancer drugs.

Our staff and postgraduate students are based in the Northern Institute for Cancer Research (NICR) or the School of Chemistry. The NICR incorporates the Newcastle Cancer Centre, a unique collaboration between Cancer Research UK and the North of England Children's Cancer Research Fund.

We are a major training base for the next generation of cancer researchers. Our Institute covers many areas of cancer research, including:
-Solid tumours and leukaemias
-Childhood and adult cancers
-Drug discovery and early phase clinical trials

We offer approximately 15 MD, PhD and integrated MRes/PhD studentships each year, including the Newcastle Cancer Centre training programme. Projects in all research areas are available to fully-funded international students.

Members of our postgraduate community come from a variety of subject backgrounds including biological and biomedical sciences, chemistry, genetics, pharmacy, medicine, dentistry and veterinary medicine.

We hold regular postgraduate seminars which you will be required to attend and where you will deliver presentations. You will also attend and present your data annually at national cancer research meetings and at least one international meeting.

Placements

Our Institute has close working relationships with companies in the pharmaceutical and biotechnology sectors.

A number of our studentships are direct collaborations with industrial partners, with opportunities to spend placements with these partners.

Facilities

Our staff and postgraduate students are based in the Northern Institute for Cancer Research (NICR) or the School of Chemistry (medicinal chemistry students).

Our laboratories contain a full range of contemporary genomic, bioinformatic, proteomic, synthetic chemistry and pharmacology equipment, and clinical research facilities.

Read less
This programme gives you in-depth knowledge of the scientific basis of drug discovery and development, which has revolutionised the pharmaceutical industry in recent years. Read more
This programme gives you in-depth knowledge of the scientific basis of drug discovery and development, which has revolutionised the pharmaceutical industry in recent years. Our involvement with international drug companies has allowed us to keep our courses fully up-to-date. With our excellent facilities, emphasis on practical work, and teaching underpinned by the latest research, you will be qualified for research and development positions in pharmaceutical companies, as well as a wide range of other roles in industry.

About the course

The programme will have a heavy emphasis on practical work and will cover the following areas:
-Pharmacological and relevant physiological principles
-Molecular biology techniques in pharmacology
-The application of bioinformatics to drug discovery
-Quantitative aspects of pharmacology
-Case studies in drug discovery
-Molecular medicine
-Neuro-degenerative diseases
-Safety evaluationResearch project

You will undertake a practical project as part of your MSc enabling you to use our excellent facilities and to gain experience working alongside researchers in our Pharmacology Research Group. Current research projects include studies in:
-Gastrointestinal pharmacology, particularly with respect to diabetes
-Angiogenesis
-Cancer
-Cannabinoids as therapeutic agents
-Molecular pharmacology of vascular disease
-Modelling pharmacokinetics

Why choose this course?

-This is an intensive programme that will provide training in pharmacology, molecular biology and their application to drug discovery, using a problem based learning approach
-You will receive training in a range of pharmacological and molecular practical techniques as well as completing a research project
-Upon completion, you will be able to enter a successful career in the pharmaceutical industry or pursue further postgraduate research
-The School of Life and Medical Science will move into a brand new science building opening in September 2015 providing us with world class laboratories for our teaching and research. At a cost of £50M the new building provides spacious naturally lit laboratories and social spaces creating an environment that fosters multi-disciplinary learning and research

Careers

Graduates of the programme will be qualified for research and development positions in the pharmaceutical industries, to progress to a research degree or to consider regulatory, marketing or management roles in industry.

Teaching methods

Upon entering the programme, students are provided with introductory material to facilitate their transition to Master's level study. Cellular Molecular Biology is taught in parallel with Core Pharmacology, which both involve a high proportion of practical work. Students will experience a range of learning styles including conventional lectures, workshops and problem based learning. Teaching in Molecular Medicine and Pharmacovigilance & Drug Discovery Development uses case studies to foster skills such as working independently or as part of a team, demonstrating initiative and problem solving. You will also study a module in Biosciences Research Methods for Masters. All assessments are coursework only (including in-class tests), which are strategically phased throughout the course to provide regular feedback.

Structure

Modules
-Biosciences Research Methods for Masters
-Cellular Molecular Biology
-Core Pharmacology
-Drug Discovery Development and Pharmacovigilance
-Molecular Medicine
-Project-Mol Biology, Biotechnology, Pharmacology

Read less
The MSc in Cancer Research is aimed at life science and medical graduates who wish to specialise in the field of cancer research. Read more
The MSc in Cancer Research is aimed at life science and medical graduates who wish to specialise in the field of cancer research. The purpose of the programme is to provide students with extensive research-laboratory training and an overarching theoretical knowledge of cancer biology. The course has a unique, research-oriented approach with taught modules, resulting in an internationally recognised MSc degree. The obtained knowledge and skillset enables our graduates to pursue a career as a research-scientist in academia, in the medical field or in the biotechnology or pharmaceutical sector.

Specifically the course aims to:

1. Provide a broad and in-depth knowledge in molecular-, cellular- and clinical cancer biology.

2. Provide knowledge in a broad range of classic as well as state-of-the-art research technologies applied in cancer research.

3. Provide training in laboratory and research skills both at basic and advanced levels by assigning students a laboratory research project through which they will develop both technical competencies and critical thinking abilities.

4. Facilitate the interdisciplinary approach of cancer research by engaging clinical and nonclinical scientists, enabling the cross-fertilisation of ideas and thus promoting medically-focused research.

The MSc in Cancer research is a modular course, consisting of 30% taught material (equalling 25 ECTS units) combined with a strong, 70% research element (equal to 65 ECTS) allowing ample time for the students to gain in-depth research exposure.

The course material is delivered using a blended learning format (combination of face-to-face/traditional-format lectures, tutorials, self-directed learning and assignments) that will not only deliver the information the students have to attain, but also trains the students how to research independently and evaluate the information critically, which are key and valuable skills for a highly qualified cancer research scientist.

The research element will encompass two semesters. After an induction phase, the students will work on one research project throughout the two semesters allowing them to acquire a broad range of research skills ranging from state-of-the-art technologies through data interpretation to experimental design and data presentation. Available research project titles in participating laboratories of the School of Natural Sciences and other programme-associated Institutes will be provided to the students from which they can choose their project options. The students will write the MSc thesis on the findings of their research project..

Overall, the knowledge and laboratory experience providesour graduates with a great advantage when competing for either academic or industry-linked careers.

For further information please visit: http://www.nuigalway.ie/courses/research-postgraduate-programmes/structured-phd/cancer-research.html


How to apply:
Applications are made online via Postgraduate Applications Centre (http://www.pac.ie/nuigalway). The following documents must be supplied:
- A Curriculum Vitae
- A personal statement of approximately 600 words explaining why the the applicant wishes to undertake the Structured MSc in Cancer Research programme and how the programme fits into their career objectives.
Academic transcripts, unless the applicant is a graduate or current student of NUI Galway.

Read less
From inhalers that ease breathing to pills and injections that destroy cancer, pharmacology affects billions of people around the world as a powerful force for good. Read more

From inhalers that ease breathing to pills and injections that destroy cancer, pharmacology affects billions of people around the world as a powerful force for good. In our MSc Pharmacology programme, you’ll discover how to harness that power to save and improve countless lives.

At GCU, you'll develop a comprehensive understanding of the science behind drugs and their effects on the human body – and master the cutting-edge techniques, laboratory bench skills and critical thinking approaches you need to succeed.

As part of our thriving, diverse and globally networked research community, you’ll investigate how the body works and what goes wrong when a disease strikes – and learn how drugs are engineered to reverse and even prevent a wide range of medical conditions.

You’ll get a world-class education through a variety of teaching methods – including lectures, seminars, practical laboratory classes and a laboratory-based research project. The programme prepares you for industry and academia alike, whether you choose employment or pursue your PhD.

What you will study

Skills for Professional Practice in Bioscience 1; Skills for Professional Practice in Bioscience 2; Current Topics in Pharmacology; Drugs and Cellular Communication; Advanced Topics in Neuropharmacology; Biomolecular studies; Drugs and Disease; Systems Pharmacology; and MSc Research Project.

Teaching methods

The learning and teaching methods we use ensure that our programme is both vocationally relevant and academically challenging. Our approach is student-centred, practical, participative and relevant to the needs of employers.

We've moved away from the traditional teacher-centric learning to a more independent learning approach, where you are encouraged to develop critical thinking skills.

Assessment methods

We use a wide range of learning and teaching methods to ensure that you have both the necessary knowledge and understanding of business and management and a portfolio of intellectual and personal skills.

Each module on the programme uses its own learning, teaching and assessment strategy to achieve learning objectives. Assessment methods vary between modules and may include unseen examinations, class tests, essays, management reports, case studies, presentations, and group work.

Graduate prospects

With an MSc Pharmacology, you’ll have the skills and knowledge you need to choose from multiple career paths.

Research pharmacology: Many of our graduates go on to work in laboratories at universities, government research institutes or in industry, conducting experiments to gain new insight into disease and developing life-changing new drugs.

Clinical pharmacology: After drugs are developed in the lab, clinical pharmacologists take the next step – focusing on application for human use. Our MSc Pharmacology prepares you for the additional training required to pursue a career in this field.

Pharmacology teaching: You might also choose to work at a university, college lecture theatre or laboratory – sharing what you've learned with the next generation.



Read less
This course increases your knowledge and skills in pharmacology and biotechnology to increase your competitiveness in the job market or complete research at PhD level. Read more

This course increases your knowledge and skills in pharmacology and biotechnology to increase your competitiveness in the job market or complete research at PhD level. If you are already employed, this course can help you to further your career prospects.

The course is delivered by internationally recognised academics who are involved in biotechnology and pharmacology research. Research projects include studying the manipulation of proteins and their application to Alzheimer's disease, epilepsy, ion channels and the development of novel drugs from natural products.

You learn in detail how drugs act at the molecular and cellular level and then how biotechnological techniques are used to produce new drugs. Examples include developing new and effective treatments for diseases, such as Alzheimer’s and rheumatoid arthritis.

You also gain experience of the latest techniques used by the pharmaceutical industry to produce and study the effects of novel drugs.

The course gives you

  • up-to-date knowledge of cellular and molecular pathology of various human diseases
  • the basis of therapeutic rationales for treating diseases and their development
  • an advanced understanding of recombinant DNA technology and how it is used to produce drugs
  • experience of the latest practical techniques, such as cell culture, quantitative PCR analysis, cloning, western blotting, and analytical techniques such as HPLC and mass spectrometry
  • the transferable and research skills to enable you to continue developing your knowledge and improve your employment potential.

Course structure

The masters (MSc) award is achieved by successfully completing 180 credits. 

The postgraduate certificate (PgCert) is achieved by successfully completing 60 credits.

The postgraduate diploma (PgDip) is achieved by successfully completing 120 credits.

Core modules:

  • Cell biology (15 credits)
  • Fundamentals of pharmacology (15 credits)
  • Molecular biology (15 credits)
  • Biotechnology (15 credits)
  • Professional development (15 credits)
  • New approaches to pharmacology (15 credits)
  • Research methods and statistics (15 credits)
  • Research project (60 credits)

Optional modules:

  • Applied biomedical techniques (15 credits)
  • Cellular and molecular basis of cancer (15 credits)
  • Pharmaceutical drug development (15 credits)
  • Human genomics and proteomics (15 credits)

Assessment

Assessment is mostly by written examination and coursework including problem solving exercises, case studies and input from practical laboratory work. Research project assessment includes a written report and viva voce.

Employability

The course improves your career prospects in areas of • biomedical sciences • medical research in universities and hospitals • the pharmaceutical industry • biotechnology companies • government research agencies.

You also develop the skills to carry out research to PhD level in pharmacology and biotechnology.

Recent MSc Pharmacology and Biotechnology graduates jobs include • project specialist at PAREXEL • quality assurance documentation assistant at Vifor Pharma • PhD at the University of Manchester • clinical research associate at AstraZeneca • workplace services analyst at Deloitte India (Offices of the US) • regulatory compliance specialist for Selerant • senior product executive at PlasmaGen BioSciences.



Read less
Before any new therapy can be used, a thorough identification of its toxicity and safety is required. Therefore, drug toxicology and safety pharmacology are central to the chemical and pharmaceutical industries, and demand for 'pre-trained' employees is extremely high. Read more
Before any new therapy can be used, a thorough identification of its toxicity and safety is required. Therefore, drug toxicology and safety pharmacology are central to the chemical and pharmaceutical industries, and demand for 'pre-trained' employees is extremely high.

Hosted by the Institute of Cancer Therapeutics, the course addresses key aspects of preclinical drug evaluation through the study of drug discovery and development; safety pharmacology; mechanisms of drug-induced toxicities; regulatory affairs and bioanalytical sciences.

It will provide you with state-of-the-art training in the area of preclinical toxicology with an emphasis on the molecular and in vivo aspects of toxicological assessment.

It is designed for individuals with a first degree in a scientific disciple who want to specialise in new medicines development or undertake employment in the pharmaceutical industry.

Why Bradford?

-Includes seminars by scientists from regulatory agencies and pharmaceutical companies
-This course is designed to meet the demand of employers and provide you with a comprehensive overview of the drug safety discipline within the drug development process

Modules

-Critical Appraisal of a Current Topic in Safety Pharmacology
-Preclinical Models for Drug Evaluation
-Research and Analytical Methods in Pharmacology
-Toxicology and Safety Pharmacology
-Experimental Design
-Molecular Mechanisms of Toxicity
-Research Project (Safety Pharmacology)

Career support and prospects

The University is committed to helping students develop and enhance employability and this is an integral part of many programmes. Specialist support is available throughout the course from Career and Employability Services including help to find part-time work while studying, placements, vacation work and graduate vacancies. Students are encouraged to access this support at an early stage and to use the extensive resources on the Careers website.

Discussing options with specialist advisers helps to clarify plans through exploring options and refining skills of job-hunting. In most of our programmes there is direct input by Career Development Advisers into the curriculum or through specially arranged workshops.

Read less
Exciting new opportunities for chemical intervention in disease have emerged based on a greater understanding of the molecular aspects of disease progression. Read more
Exciting new opportunities for chemical intervention in disease have emerged based on a greater understanding of the molecular aspects of disease progression. Drug discovery combines the expertise of medicinal chemists required in translating the understanding of the molecular aspects of disease progression to the identification of suitable chemical entities, and the process of optimisation that ultimately leads to the discovery of new medicines.

This exciting course run by the Institute of Cancer Therapeutics is designed to provide students with a 'state-of-the-art' education in modern drug discovery, which meets the demand of employers in the pharmaceutical industry.

Opportunities to learn the latest innovations in drug discovery are provided, including computer-aided drug design and techniques in parallel synthesis, as well as electronic data management.

Why Bradford?

-The course provides an expert view of the use of recent knowledge and up- to-the minute specialised approaches to discover novel drugs to help fight disease and increase the quality of life for patients
-It benefits from the multidisciplinary team of researchers in the field of drug design, synthesis, screening, pharmacology and toxicology both at the University and through our extensive links with experts at other universities and industry
-Students on the course will also benefit from working in excellent research laboratories in a research focused environment

Modules

Core modules
-Critical Appraisal of a Current Topic in Drug Discovery
-Principles of Drug Discovery
-Research and Analytical Methods
-Research Project in Drug Discovery

Option modules
-Molecular Basis of Cancer and Cancer Therapy
-Toxicology and Safety Pharmacology
-Case Studies in Drug Discovery
-Chemical Toolbox for Drug Discovery
-Molecular Mechanisms of Toxicity

Career support and prospects

The University is committed to helping students develop and enhance employability and this is an integral part of many programmes. Specialist support is available throughout the course from Career and Employability Services including help to find part-time work while studying, placements, vacation work and graduate vacancies. Students are encouraged to access this support at an early stage and to use the extensive resources on the Careers website.

Discussing options with specialist advisers helps to clarify plans through exploring options and refining skills of job-hunting. In most of our programmes there is direct input by Career Development Advisers into the curriculum or through specially arranged workshops.

Many students go on to study for PhDs either at Bradford or elsewhere. Recent graduates are studying at Dundee, Newcastle and Glasgow universities. Those in employment are in R&D and clinical research roles.

Read less
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of treating cancer. Read more
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of treating cancer.

This will be underpinned by a thorough knowledge of cancer biology and pathology and research methodologies.

This knowledge will provide an excellent grounding in the development, use and evaluation of cancer therapies, which will enhance career prospects in many areas of early phase clinical trials and clinical drug development in the cancer setting.

Compulsory Modules

• Ablative Therapies
• Cancer Biology
• Cancer Pharmacology
• Cancer Prevention & Screening
• Drug Development
• Molecular Diagnostic & Therapeutics
• Molecular Targeted Therapies and Immunotherapy for Blood Cancer
• Research Methods
• Site Specific Tumour Treatment

Elective Modules

• Genomic Approaches to Human Diseases
• Paediatric & Adolescent Oncology
• Pathology of Cancer

Core Module for MSc

• Dissertation.

Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, our programmes are all taught by experts in the field.

Find out more about the BCI at http://www.bci.qmul.ac.uk/study-with-us

Read less
This programme aims to provide you with a clear understanding of molecular and cellular biology that is fundamental to cancer biology and cancer research. Read more
This programme aims to provide you with a clear understanding of molecular and cellular biology that is fundamental to cancer biology and cancer research.

You will learn how research in this area has advanced the treatment and diagnoses of cancer, and gain knowledge of how new therapies are developed, evaluated and implemented.

You will gain a thorough knowledge of research methodologies and laboratory techniques, which you will fully utilise in the laboratory research project stage. The valuable research experience you will gain from working with leading cancer experts, will give you a solid foundation upon which a future career in scientific research can be built.

Compulsory Modules

• Biological Therapies
• Cancer Biology
• Cancer Pharmacology
• Drug Development
• Genomic Approaches to Human Diseases
• Molecular Diagnostic & Therapeutics
• Pathology of Cancer
• Research Lab Skills
• Research Methods

Elective Modules

• Cancer Prevention & Screening
• Paediatric & Adolescent Oncology

Core Module for MSc

• Lab project


Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, our programmes are all taught by experts in the field.

To find out more about BCI visit http://www.bci.qmul.ac.uk/study-with-us

Read less
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of clinical oncology and the development, evaluation and implementation of new treatments. Read more
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of clinical oncology and the development, evaluation and implementation of new treatments.

This will be underpinned by a thorough knowledge of cancer biology and pathology, drug development and research methodologies.

This knowledge will provide you with a good grounding in oncology within a clinical setting which will enhance prospects for those wanting to pursue a clinical academic career.

Compulsory Modules

• Ablative Therapies
• Cancer Biology
• Cancer Pharmacology
• Cancer Prevention & Screening
• Drug Development
• Genomic Approaches to Human Diseases
• Imaging
• Paediatric & Adolescent Oncology
• Pathology of Cancer
• Research Methods
• Site Specific Tumour Treatment

Elective Modules

• Biological Therapies
• Molecular Targeted Therapies and Immunotherapy for Blood Cancer

Core Module for MSc

• Dissertation

Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, all our programmes are taught by experts in the field.

To find out more about BCI visit http://www.bci.qmul.ac.uk/study-with-us

Read less
The area of cancer immunotherapy considers how to use conventional therapies including surgery, radiation and chemotherapy. Read more
The area of cancer immunotherapy considers how to use conventional therapies including surgery, radiation and chemotherapy. Whilst these treatment have served well and new drugs will continue to be designed, clinical trials over the last five years have shown that boosting the body’s immune system, whose main task is to deal with invading pathogens, can help our immune system to destroy tumour cells. Many of the new immunotherapies may be tested in combination with more conventional treatments or tested alone, but investigators and oncologists now believe immunotherapy, initially combined with pharmacological treatments, will soon provide curative therapies and certainly give many patients a new lease of life.

More about this course

Worldwide the incidence of cancer is increasing, and is expected to reach 22 million new cases per year by 2030. In addition to treatments such as radiotherapy and surgery, chemotherapy has a vital role to play in prolonging the lives of patients.

The aims of the Cancer Immunotherapy MSc are to:
-Provide an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving
-Review the biology of cancer with respect to genetics, pathological considerations, and the molecular changes within cells which are associated with the progression of the disease
-Enhance intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data
-Deliver a programme of advanced study to equip students for a future career in anti-cancer drug and immunotherapy development
-Cover new areas in immunotherapy (some of which may enhance existing pharmacological therapies including: History of immunotherapy and review of immune system; Monoclonal antibodies in cancer therapy and prevention; DNA vaccines against cancer; Adoptive T cell therapy; Dendritic cell vaccines; Antibodies that stimulate immunity; Adjuvant development for vaccines; Epigenetics and cancer: improving immunotherapy; Immuno-chemotherapy: integration of therapies; Exosomes and Microvesicles (EMVs) in cancer therapy and diagnosis; Dendritic cell vaccine development and Pox virus cancer vaccine vectors; Microbial causes of cancer and vaccination

Students will have access to highly qualified researchers and teachers in pharmacology and immunology, including those at the Cellular and Molecular Immunology Research Centre. Skills gained from research projects are therefore likely to be highly marketable in industry, academia and in the NHS. Students will be encouraged to join the British Society of Immunology and the International Society of Extracellular Vesicles.

Assessment is a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.

Modular structure

The modules listed below are for the academic year 2016/17 and represent the course modules at this time. Modules and module details (including, but not limited to, location and time) are subject to change over time.

Year 1 modules include:
-Advanced Immunology (core, 20 credits)
-Cancer Immunotherapy (core, 20 credits)
-Cancer Pharmacology (core, 20 credits)
-Cancer: Diagnosis and Therapy (core, 20 credits)
-Molecular Oncology (core, 20 credits)
-Research Project (core, 60 credits)
-Scientific Frameworks for Research (core, 20 credits)

After the course

Students will have many opportunities to work in industry. There are established industries working hard to develop cancer immunotherapies including Bristol-Myers Squibbs, MERCK, AstraZeneca and Roche. There are also an innumerate number of start-up companies appearing including Omnis Pharma, UNUM Therapeutics and Alpine Immune Sciences.

Students will also have ample opportunity for future postgraduate study either within the School of Human Sciences and the Cellular and Molecular Immunology Centre at the MPhil/PhD level or beyond, even with some of our research partners within the UK, Europe and beyond.

Read less
This M.Sc. program in Translational Oncology will provide high-quality training for basic scientists and clinicians in the theoretical and practical aspects of the causes and treatment of cancer. Read more
This M.Sc. program in Translational Oncology will provide high-quality training for basic scientists and clinicians in the theoretical and practical aspects of the causes and treatment of cancer. A major focus of the programme is the cellular genetic and epigenetic basis of cancer. The course also covers the scientific and clinical challenges pertinent to the management of site specific cancers, and all aspects of cancer treatment from standard therapies to 'individualised' molecular targeted therapies. The focus of the course is research led teaching in the practical aspects of translational cancer research. This innovative M.Sc. program in Translational Oncology is aimed at scientists and doctors in training who wish to:

Develop their research skills
Broaden their expertise in oncology
Develop advanced knowledge in specific areas of scientific, translational and clinical oncology.

The proposed course will offer an opportunity for graduates from a variety of backgrounds to specifically train in translational oncology in advance of undertaking an MD or PhD. Modules are taught using a variety of methods including lectures, tutorials, workshops and laboratory practicals. Lectures are provided by leaders in the field of translational oncology from both scientific and medical backgrounds. The core modules are Cellular and Molecular Oncology, Cancer Epigenetics, Disease Specific Cancers, Radiation / Chemotherapy and Molecular Targeted Therapies, Tumour Immunology, Molecular Pathology and Imaging, Clinical Statsitics and Research Skills. Students can tailor the course to their interests with optional modules in Obesity, metabolism and Cancer, Gemomic Instability, Cancer Drug Development, Tumour Microenvironment, Clinical Pharmacology, and Surgical Oncology and Economics. Students will be required to submit a dissertation based on an emperical research project conducted in one of the many oncology groups located within or affiliated with Trinity College Dublin and the Institute of Molecular Medicine. Opportunities for national and international placements to conduct research projects will also be available in collaborating universities, hospitals and industry.

All applicants should provide two academic or clinical references confirming their eligibility and suitability for the course, before their application can be considered. Applicants should also include a 500 word personal statement addressing why they are interested in the course, their suitability for the programme and how it will impact on their future career development. Applications for admission to the course should be made through the online system no later than July 31st. Late applications will be considered provided places are available.

Read less
We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments. Read more

We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments.

As a student you will be registered with a University research institute, for many this is the Institute for Cellular Medicine (ICM). You will be supported in your studies through a structured programme of supervision and training via our Faculty of Medical Sciences Graduate School.

We undertake the following areas of research and offer MPhil, PhD and MD supervision in:

Applied immunobiology (including organ and haematogenous stem cell transplantation)

Newcastle hosts one of the most comprehensive organ transplant programmes in the world. This clinical expertise has developed in parallel with the applied immunobiology and transplantation research group. We are investigating aspects of the immunology of autoimmune diseases and cancer therapy, in addition to transplant rejection. We have themes to understand the interplay of the inflammatory and anti-inflammatory responses by a variety of pathways, and how these can be manipulated for therapeutic purposes. Further research theme focusses on primary immunodeficiency diseases.

Dermatology

There is strong emphasis on the integration of clinical investigation with basic science. Our research include:

  • cell signalling in normal and diseased skin including mechanotransduction and response to ultraviolet radiation
  • dermatopharmacology including mechanisms of psoriatic plaque resolution in response to therapy
  • stem cell biology and gene therapy
  • regulation of apoptosis/autophagy
  • non-melanoma skin cancer/melanoma biology and therapy.

We also research the effects of UVR on the skin including mitochondrial DNA damage as a UV biomarker.

Diabetes

This area emphasises on translational research, linking clinical- and laboratory-based science. Key research include:

  • mechanisms of insulin action and glucose homeostasis
  • insulin secretion and pancreatic beta-cell function
  • diabetic complications
  • stem cell therapies
  • genetics and epidemiology of diabetes.

Diagnostic and therapeutic technologies

Focus is on applied research and aims to underpin future clinical applications. Technology-oriented and demand-driven research is conducted which relates directly to health priority areas such as:

  • bacterial infection
  • chronic liver failure
  • cardiovascular and degenerative diseases.

This research is sustained through extensive internal and external collaborations with leading UK and European academic and industrial groups, and has the ultimate goal of deploying next-generation diagnostic and therapeutic systems in the hospital and health-care environment.

Kidney disease

There is a number of research programmes into the genetics, immunology and physiology of kidney disease and kidney transplantation. We maintain close links between basic scientists and clinicians with many translational programmes of work, from the laboratory to first-in-man and phase III clinical trials. Specific areas:

  • haemolytic uraemic syndrome
  • renal inflammation and fibrosis
  • the immunology of transplant rejection
  • tubular disease
  • cystic kidney disease.

The liver

We have particular interests in:

  • primary biliary cirrhosis (epidemiology, immunobiology and genetics)
  • alcoholic and non-alcoholic fatty liver disease
  • fibrosis
  • the genetics of other autoimmune and viral liver diseases

Magnetic Resonance (MR), spectroscopy and imaging in clinical research

Novel non-invasive methodologies using magnetic resonance are developed and applied to clinical research. Our research falls into two categories:

  • MR physics projects involve development and testing of new MR techniques that make quantitative measurements of physiological properties using a safe, repeatable MR scan.
  • Clinical research projects involve the application of these novel biomarkers to investigation of human health and disease.

Our studies cover a broad range of topics (including diabetes, dementia, neuroscience, hepatology, cardiovascular, neuromuscular disease, metabolism, and respiratory research projects), but have a common theme of MR technical development and its application to clinical research.

Musculoskeletal disease (including auto-immune arthritis)

We focus on connective tissue diseases in three, overlapping research programmes. These programmes aim to understand:

  • what causes the destruction of joints (cell signalling, injury and repair)
  • how cells in the joints respond when tissue is lost (cellular interactions)
  • whether we can alter the immune system and ‘switch off’ auto-immune disease (targeted therapies and diagnostics)

This research theme links with other local, national and international centres of excellence and has close integration of basic and clinical researchers and hosts the only immunotherapy centre in the UK.

Pharmacogenomics (including complex disease genetics)

Genetic approaches to the individualisation of drug therapy, including anticoagulants and anti-cancer drugs, and in the genetics of diverse non-Mendelian diseases, from diabetes to periodontal disease, are a focus. A wide range of knowledge and experience in both genetics and clinical sciences is utilised, with access to high-throughput genotyping platforms.

Reproductive and vascular biology

Our scientists and clinicians use in situ cellular technologies and large-scale gene expression profiling to study the normal and pathophysiological remodelling of vascular and uteroplacental tissues. Novel approaches to cellular interactions have been developed using a unique human tissue resource. Our research themes include:

  • the regulation of trophoblast and uNk cells
  • transcriptional and post-translational features of uterine function
  • cardiac and vascular remodelling in pregnancy

We also have preclinical molecular biology projects in breast cancer research.

Respiratory disease

We conduct a broad range of research activities into acute and chronic lung diseases. As well as scientific studies into disease mechanisms, there is particular interest in translational medicine approaches to lung disease, studying human lung tissue and cells to explore potential for new treatments. Our current areas of research include:

  • acute lung injury - lung infections
  • chronic obstructive pulmonary disease
  • fibrotic disease of the lung, both before and after lung transplantation.

Pharmacology, Toxicology and Therapeutics

Our research projects are concerned with the harmful effects of chemicals, including prescribed drugs, and finding ways to prevent and minimise these effects. We are attempting to measure the effects of fairly small amounts of chemicals, to provide ways of giving early warning of the start of harmful effects. We also study the adverse side-effects of medicines, including how conditions such as liver disease and heart disease can develop in people taking medicines for completely different medical conditions. Our current interests include: environmental chemicals and organophosphate pesticides, warfarin, psychiatric drugs and anti-cancer drugs.

Pharmacy

Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.



Read less

Show 10 15 30 per page



Cookie Policy    X